Clinical Trials List
Protocol NumberD7261C00004
Not yet recruiting
2026-06-01 - 2028-12-31
Phase III
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 林承緯 Division of Nephrology
- Yung-Chang Chen Division of Nephrology
- Guan-Hsing Chen Division of Nephrology
- Cheng-Chia Lee Division of Nephrology
- 吳欣旭 Division of Nephrology
- Jia-Hong Lin Division of Nephrology
- 范佩君 Division of Nephrology
- Chun-Hsiu Liu Division of Nephrology
- 鄭昌錡 Division of Nephrology
- 陳怡文 Division of Nephrology
- Chih-Shiang Chang Division of Nephrology
- 王涵芸 Division of Nephrology
Co-Principal Investigator
- 陳怡婷 Division of Nephrology
- - - Division of Nephrology
- CHUN-FU LAI Division of Nephrology
- YU-HSIANG CHOU Division of Nephrology
- FAN-CHI CHANG Division of Nephrology
- 黃道民 Division of Nephrology
- 謝易庭 Division of Nephrology
- WEN-CHIH CHIANG Division of Nephrology
Co-Principal Investigator
- 林冠宏 Division of Nephrology
- Li-Yee Hong Division of Nephrology
- YUNG-HO HSU Division of Nephrology
- Yu-Wei Chen Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- Chia-Te Liao Division of Nephrology
- 高芷華 Division of Nephrology
- 賴史忠 Division of Nephrology
- Mai-Szu Wu Division of Nephrology
Co-Principal Investigator
- 傅崇銘 Division of Nephrology
- 黃鏘綺 Division of Nephrology
- 姜威宇 Division of Nephrology
- CHIH-CHAO YANG Division of Nephrology
- 許淳惟 Division of Nephrology
- Wen-Chin Lee Division of Nephrology
- 邱千華 Division of Nephrology
- 周嘉安 Division of Nephrology
- 李岳庭 Division of Nephrology
- 蘇昱日 Division of Nephrology
Co-Principal Investigator
- Te-Chao Fang Division of Nephrology
- I-WEN WU Division of Nephrology
- 陳靜怡 Division of Nephrology
- Chih-Chin Kao Division of Nephrology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
144 participants
-
Global
900 participants
